| Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis M Yin, M Joshi, RP Meijer, M Glantz, S Holder, HA Harvey, M Kaag, ... The oncologist 21 (6), 708-715, 2016 | 496 | 2016 |
| European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines JA Witjes, HM Bruins, A Carrión, R Cathomas, E Compérat, JA Efstathiou, ... European urology 85 (1), 17-31, 2024 | 272 | 2024 |
| Mouse and human urothelial cancer organoids: A tool for bladder cancer research J Mullenders, E de Jongh, A Brousali, M Roosen, JPA Blom, H Begthel, ... Proceedings of the National Academy of Sciences 116 (10), 4567-4574, 2019 | 264 | 2019 |
| EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU … JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... European urology 77 (2), 223-250, 2020 | 203 | 2020 |
| Long-term follow-up after laser therapy for penile carcinoma RP Meijer, TA Boon, GEPM van Venrooij, CJ Wijburg Urology 69 (4), 759-762, 2007 | 132 | 2007 |
| Prospective validation of gallium-68 prostate specific membrane antigen-positron emission tomography/computerized tomography for primary staging of prostate cancer LWM van Kalmthout, HHE van Melick, J Lavalaye, RP Meijer, A Kooistra, ... The Journal of urology 203 (3), 537-545, 2020 | 127 | 2020 |
| Treatment of high-grade non–muscle-invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations … MO Grimm, AG van der Heijden, M Colombel, T Muilwijk, ... European urology 78 (5), 690-698, 2020 | 122 | 2020 |
| Long-term outcomes of follow-up for initially localised clear cell renal cell carcinoma: RECUR database analysis S Dabestani, C Beisland, GD Stewart, K Bensalah, E Gudmundsson, ... European urology focus 5 (5), 857-866, 2019 | 106 | 2019 |
| EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU … A Horwich, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... Annals of Oncology 30 (11), 1697-1727, 2019 | 95 | 2019 |
| Carboplatin based induction chemotherapy for nonorgan confined bladder cancer—a reasonable alternative for cisplatin unfit patients? LS Mertens, RP Meijer, JM Kerst, AM Bergman, H van Tinteren, ... The Journal of urology 188 (4), 1108-1114, 2012 | 66 | 2012 |
| Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin EEF van de Putte, LS Mertens, RP Meijer, MS van der Heijden, A Bex, ... World journal of urology 34, 157-162, 2016 | 63 | 2016 |
| Induction chemotherapy followed by surgery in node positive bladder cancer RP Meijer, LS Mertens, BW van Rhijn, A Bex, HG van der Poel, ... Urology 83 (1), 134-139, 2014 | 61 | 2014 |
| Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: a systematic … JM Blok, I Pluim, G Daugaard, T Wagner, K Jóźwiak, EA Wilthagen, ... BJU international 125 (3), 355-368, 2020 | 60 | 2020 |
| Focal MRI-guided salvage high-dose-rate brachytherapy in patients with radiorecurrent prostate cancer M Maenhout, M Peters, M van Vulpen, MA Moerland, RP Meijer, ... Technology in cancer research & treatment 16 (6), 1194-1201, 2017 | 58 | 2017 |
| Prostate sparing cystectomy for bladder cancer: 20-year single center experience LS Mertens, RP Meijer, RR de Vries, JA Nieuwenhuijzen, ... The Journal of urology 191 (5), 1250-1255, 2014 | 57 | 2014 |
| Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone LS Mertens, RP Meijer, W Meinhardt, HG van der Poel, A Bex, JM Kerst, ... BJU international 114 (1), 67-74, 2014 | 56 | 2014 |
| Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodes RPP Meijer, CJM Nunnink, AE Wassenaar, A Bex, HG Van der Poel, ... The Journal of urology 187 (2), 446-450, 2012 | 50 | 2012 |
| Robot-assisted radical cystectomy versus open radical cystectomy in bladder cancer patients: a multicentre comparative effectiveness study CJ Wijburg, CTJ Michels, G Hannink, JPC Grutters, MM Rovers, JA Witjes, ... European Urology 79 (5), 609-618, 2021 | 49 | 2021 |
| The impact of histological subtype on the incidence, timing, and patterns of recurrence in patients with renal cell carcinoma after surgery—results from RECUR Consortium Y Abu-Ghanem, T Powles, U Capitanio, C Beisland, P Järvinen, ... European urology oncology 4 (3), 473-482, 2021 | 47 | 2021 |
| Renal cell carcinoma: alternative nephron-sparing treatment options for small renal masses, a systematic review FM Prins, LGW Kerkmeijer, AA Pronk, EJPA Vonken, RP Meijer, A Bex, ... Journal of endourology 31 (10), 963-975, 2017 | 47 | 2017 |
